Literature DB >> 3159509

Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy.

P Spirito, B J Maron, F Chiarella, P Bellotti, R Tramarin, M Pozzoli, C Vecchio.   

Abstract

To investigate the relationship between diastolic abnormalities and left ventricular hypertrophy, 52 patients with hypertrophic cardiomyopathy (HCM) and 22 normal subjects were studied with digitized M mode echocardiography and two-dimensional echocardiography. Echocardiographic indexes of diastolic function were compared in patients with different extent of left ventricular hypertrophy. Time interval from minimum left ventricular internal dimension to mitral valve opening and time to peak rate of increase in left ventricular internal dimension were significantly prolonged (80 +/- 31 and 100 +/- 37 msec, respectively) in patients with HCM and the most extensive left ventricular hypertrophy compared with those in patients with mild left ventricular hypertrophy (59 +/- 25 and 74 +/- 34 msec, respectively; p less than .01). Furthermore, peak rate of posterior wall diastolic excursion was significantly reduced in those patients with HCM and posterior wall hypertrophy (8.3 +/- 4.0 cm/sec) compared with that in patients with HCM but normal posterior wall thickness (11.2 +/- 3.4 cm/sec; p less than .002). However, abnormal M mode echocardiographic indexes of diastolic function were also identified in a substantial proportion of patients (i.e., 73%) with HCM and only mild left ventricular hypertrophy. In these patients, time interval from minimum left ventricular internal dimension to mitral valve opening (59 +/- 25 msec), peak rate (12 +/- 4 cm/sec), and time to peak rate of increase in left ventricular internal dimension (74 +/- 34 msec) were significantly different from normal (25 +/- 12 msec, 21 +/- 3 cm/sec, and 49 +/- 12 msec, respectively; p less than .01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3159509     DOI: 10.1161/01.cir.72.2.310

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  Athlete"s heart and hypertrophic cardiomyopathy.

Authors:  A Pelliccia
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

2.  Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects.

Authors:  Quirino Ciampi; Sandro Betocchi; Anna Violante; Raffaella Lombardi; Maria Angela Losi; Giovanni Storto; Fiore Manganelli; Carlo Gabriele Tocchetti; Mariano Aversa; Elpidio Pezzella; Filippo Finizio; Alberto Cuocolo; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

3.  Early diastolic function during exertion influences exercise intolerance in patients with hypertrophic cardiomyopathy.

Authors:  Kei Mizukoshi; Kengo Suzuki; Kihei Yoneyama; Ryo Kamijima; Seisyou Kou; Manabu Takai; Masaki Izumo; Akio Hayashi; Eiji Ohtaki; Yoshihiro J Akashi; Naohiko Osada; Kazuto Omiya; Tomoo Harada; Sachihiko Nobuoka; Fumihiko Miyake
Journal:  J Echocardiogr       Date:  2012-10-19

4.  Diastolic flow velocity pattern of the left anterior descending coronary artery in hypertrophied heart, with special reference to the difference between hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy.

Authors:  Nobuo Fukuda; Yamato Fukuda; Satofumi Morishita; Koichi Sakabe; Hisanori Shinohara; Yoshiyuki Tamura
Journal:  J Echocardiogr       Date:  2010-01-13

5.  Effect of regional myocardial perfusion abnormalities on regional myocardial early diastolic function in patients with hypertrophic cardiomyopathy.

Authors:  H Yamanari; M Kakishita; Y Fujimoto; K Hashimoto; T Kiyooka; Y Katayama; F Otsuka; T Emori; S Uchida; T Ohe
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

6.  Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.

Authors:  Seon Woon Kim; Seung Woo Park; Seong-Hoon Lim; Sung Uk Kwon; Yu Jeong Choi; Man Ki Park; Sang-Chol Lee; Sang Hoon Lee; Jeong Euy Park; Eun-Seok Jeon
Journal:  Clin Cardiol       Date:  2006-04       Impact factor: 2.882

7.  The Role of Calcium/Calmodulin-Dependent Protein Kinase II Activation in Hypertrophic Cardiomyopathy.

Authors:  Jil C Tardiff
Journal:  Circulation       Date:  2016-11-29       Impact factor: 29.690

8.  Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity.

Authors:  Khalid Abozguia; Ganesh Nallur-Shivu; Thanh T Phan; Ibrar Ahmed; Rajat Kalra; Rebekah A Weaver; William J McKenna; John E Sanderson; Perry Elliott; Michael P Frenneaux
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

Review 9.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

10.  Effects of increasing afterload on early diastolic dysfunction in hypertrophic non-obstructive cardiomyopathy.

Authors:  G Hausdorf; V Siglow; C A Nienaber
Journal:  Br Heart J       Date:  1988-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.